Medications for Eosinophilic Esophagitis

2 results

  • dupixent

    (Dupilumab)
    sanofi-aventis U.S. LLC
    DUPIXENT is indicated for treating moderate-to-severe atopic dermatitis in patients 6 months and older, asthma in patients 6 years and older, chronic rhinosinusitis with nasal polyps in patients 12 and older, eosinophilic esophagitis, prurigo nodularis, inadequate COPD management, chronic spontaneous urticaria over 12, and bullous pemphigoid in adults.

  • eohilia

    (Budesonide)
    TAKEDA PHARMACEUTICALS AMERICA, INC.
    EOHILIA™ is indicated for 12 weeks of treatment in adults and pediatric patients aged 11 and older with eosinophilic esophagitis (EoE). It is not proven safe or effective for EoE treatment beyond 12 weeks.